Routine compliance certificate under SEBI Regulation 74(5) for Sep 2026 quarter

Compliance View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+2.4%Reaction day

₹71.80

prior close

—

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-2.8%+5.1% vs market

Pharmaceuticals peers, median of 172sector-2.5%+4.8% vs sector

On the reaction day the stock moved 5.1 pts more than Nifty Microcap 250 and 4.8 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

—

10m

—

15m

—

30m

—

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+2.4-2.8+5.1-2.5+4.8

Next day

+1.9-2.5+4.5-2.6+4.5

-2.5-1.7-0.8-2.5+0.0

-5.3-1.5-3.8-2.5-2.8

-2.5-0.8-1.7-2.5+0.0

-2.5-2.4-0.1-3.2+0.7

-2.5-3.4+0.9-4.4+1.9

15d

—————

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 172Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Colinz Laboratories has submitted to BSE the compliance certificate from its Registrar and Share Transfer Agent, Bigshare Services, under SEBI Regulation 74(5) for the quarter ended 30 September 2026. The certificate confirms that shares received for dematerialization were confirmed to the depositories and the register of members was updated within 15 days. This is a standard procedural filing required of listed companies every quarter and carries no business or financial information.

Likely market impact

Routine regulatory compliance. No effect on operations, financials, or shareholder value.